SO-009 Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR-T therapy in metastatic colorectal cancer Authors CutsemE Van 1 MachielsJ 2 den EyndeM Van 3 PrenenH 4 HendliszA 5 ShazaL 5 CarrascoJ 6 CanonJ 7 SotiropoulouP 8 BremanE 8 AlcantarE 8 FlamentA 8 1University Hospitals Gasthuisberg, Leuven and KU Leuven, Leuven, Belgium 2St-Luc University Hospital, Brussels, Belgium 3Clin. Univ. St-Luc Bruxelles, Brussels, Belgium 4University Hospital Gasthuisberg, Leuven, Belgium 5Institut Jules Bordet, Brussels, Belgium 6Grand Hôpital de Charleroi, Charleroi, Belgium 7Service d’Oncologie-Hématologie, Grand Hôpital de Charleroi, Charleroi, Belgium 8Celyad, Mont-Saint-Guibert, Belgium